Structure-based design of potent CDK1 inhibitors derived from olomoucine Pascal FuretJuerg ZimmermannPatricia Imbach OriginalPaper Pages: 403 - 409
Computer based screening of compound databases: 1. Preselection of benzamidine-based thrombin inhibitors Thomas FoxEric E.J. Haaksma OriginalPaper Pages: 411 - 425
Pharmacophore modelling of structurally unusual diltiazem mimics at L-type calcium channels K.-J. SchleiferE. Tot OriginalPaper Pages: 427 - 433
Evaluation of docking/scoring approaches: A comparative study based on MMP3 inhibitors Sookhee HaRomana AndreaniIngo Muegge OriginalPaper Pages: 435 - 448
A genetic algorithm for the automated generation of small organic molecules: Drug design using an evolutionary algorithm Dominique DouguetEtienne ThoreauGérard Grassy OriginalPaper Pages: 449 - 466
Pseudoreceptor model for ryanodine derivatives at calcium release channels Klaus-Jürgen Schleifer OriginalPaper Pages: 467 - 475
Use of electron-electron repulsion energy as a molecular descriptor in QSAR and QSPR studies Xavier GironésLluís AmatRamon Carbó-Dorca OriginalPaper Pages: 477 - 485
De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks Gisbert SchneiderMan-Ling LeePetra Schneider OriginalPaper Pages: 487 - 494
Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations Vijay M. GokhaleVithal M. Kulkarni OriginalPaper Pages: 495 - 506